Clinical and epidemiologic aspects of oral contraceptive safety.
D000568:Amenorrhea / Q000139:chemically induced; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D050260:Carbohydrate Metabolism; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004812:Epidemiologic Methods; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D009747:Nutritional Physiological Phenomena; D011374:Progesterone / Q000009:adverse effects; D011372:Progestins / Q000009:adverse effects; D013739:Testosterone / Q000009:adverse effects; D013923:Thromboembolism / Q000139:chemically induced
D003276:Contraceptives, Oral; D011372:Progestins; D013739:Testosterone; D011374:Progesterone